Effects of bacterial infection on airway antimicrobial peptides and proteins in COPD

Ganapathi Iyer Parameswaran1, Sanjay Sethi2, Timothy F Murphy3

  • 1Division of Infectious Diseases, Department of Medicine, University at Buffalo, State University of New York, Buffalo, NY; VA Western New York Healthcare System, Buffalo, NY.

Chest
|February 26, 2011
PubMed
Abstract

Insights

Bacterial colonization and exacerbations in COPD patients significantly alter airway antimicrobial peptide (AMP) levels. Specific AMPs like lysozyme and SLPI decrease, while LL-37 increases during these events.

Area of Science:

  • Pulmonary Medicine
  • Infectious Disease
  • Immunology

Background:

  • Chronic Obstructive Pulmonary Disease (COPD) patients experience frequent airway infections.
  • Nontypeable Haemophilus influenzae (NTHI) and Moraxella catarrhalis are key pathogens causing COPD exacerbations.
  • Antimicrobial peptides (AMPs) are crucial for innate lung immunity, but their role during bacterial colonization and exacerbation in COPD is unclear.

Purpose of the Study:

  • To investigate the impact of new bacterial strain acquisition on airway AMP levels in COPD patients.
  • To quantify changes in specific AMPs (lysozyme, lactoferrin, LL-37, SLPI) during colonization and exacerbation.

Main Methods:

  • Analysis of 153 sputum samples from 11 COPD patients over 6 years.
  • Categorization of samples into culture-negative, colonization, and exacerbation groups.
  • Quantification of lysozyme, lactoferrin, LL-37, and SLPI using ELISA.

Main Results:

  • Sputum lysozyme levels decreased significantly during NTHI and M. catarrhalis colonization and exacerbation.
  • Secretory leukocyte protease inhibitor (SLPI) levels were lower during exacerbation and M. catarrhalis colonization.
  • LL-37 levels were elevated during exacerbation by both pathogens; lactoferrin levels showed no significant change.

Conclusions:

  • Acquisition of NTHI and M. catarrhalis leads to significant alterations in airway AMP profiles in COPD.
  • AMP level changes are more pronounced during exacerbations compared to colonization.
  • Airway AMPs are likely critical for pathogen clearance and influencing clinical outcomes in COPD infections.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...